Abstract
In light of the proliferation of recent research into social function in neurofibromatosis type 1 (NF1), a systematic review and meta-analysis is required to synthesise data and place findings within the context of a theoretical framework. This paper reviews findings from research into social function and autism spectrum disorder (ASD) in children and adults with NF1 and integrates these findings with the Socio-Cognitive Integration Abilities Model (SOCIAL). It also critically appraises links between social outcomes, internal and external factors moderating social functioning, cognitive domains implicated in social functioning, and underlying neural pathology in NF1. A systematic literature search conducted in MedLine (Ovid), PsycINFO (Ovid), Embase (Ovid), and PubMed electronic databases yielded 35 papers that met inclusion criteria for the systematic review. Out of these papers, 22 papers provided sufficient data for meta-analysis. Findings from this review and meta-analysis provide evidence that children and adults with NF1 exhibit significantly higher prevalence and severity of social dysfunction and ASD symptomatology. To date, very few studies have examined social cognition in NF1 but results indicate the presence of both perceptual and higher-level impairments in this population. The results of this review also provide support for age, gender, and comorbid ADHD as moderating factors for social outcomes in NF1. Suggestions for future research are offered to further our understanding of the social phenotype in NF1 and to facilitate the development of targeted interventions.
Similar content being viewed by others
References
Abdi, B. (2010). Gender differences in social skills, problem behaviours and academic competence of Iranian kindergarten children based on their parent and teacher ratings. Procedia-Social and Behavioral Sciences, 5, 1175–1179.
Achenbach, T. M. (1991). Manual for the Child Behavior Checklist/4–18 and 1991 profile: Department of Psychiatry. VT: University of Vermont Burlington.
Achenbach, T. M., McConaughy, S. H., & Howell, C. T. (1987). Child/adolescent behavioral and emotional problems: Implications of cross-informant correlations for situational specificity. Psychological Bulletin, 101(2), 213–232.
Addington, J., & Addington, D. (1999). Neurocognitive and social functioning in schizophrenia. Schizophrenia Bulletin, 25(1), 173–182.
Adolphs, R. (2001). The neurobiology of social cognition. Current Opinion in Neurobiology, 11(2), 231–239.
Adviento, B., Corbin, I. L., Widjaja, F., Desachy, G., Enrique, N., Rosser, T., Risi, S., Marco, E. J., Hendren, R. L., Bearden, C. E., Rauen, K. A., & Weiss, L. A. (2014). Autism traits in the RASopathies. Journal of Medical Genetics, 51(1), 10–20.
Allen, T., Willard, V. W., Anderson, L. M., Hardy, K. K., & Bonner, M. J. (2016). Social functioning and facial expression recognition in children with neurofibromatosis type 1. Journal of Intellectual Disability Research, 60(3), 282–293.
Anderson, V., & Beauchamp, M. H. (2012). Developmental social neuroscience and childhood brain insult: Theory and practice: Guilford press.
Angkustsiri, K., Goodlin-Jones, B., Deprey, L., Brahmbhatt, K., Harris, S., & Simon, T. J. (2014). Social impairments in chromosome 22q11. 2 deletion syndrome (22q11. 2DS): Autism spectrum disorder or a different endophenotype? Journal of Autism and Developmental Disorders, 44(4), 739–746.
Anzures-Cabrera, J., & Higgins, J. (2010). Graphical displays for meta-analysis: An overview with suggestions for practice. Research Synthesis Methods, 1(1), 66–80.
Barton, B., & North, K. (2004). Social skills of children with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 46(8), 553–563.
Barton, B., & North, K. (2007). The self-concept of children and adolescents with neurofibromatosis type 1. Child: Care, Health & Development, 33(4), 401–408.
Baskin Jr., H. J. (2008). The pathogenesis and imaging of the tuberous sclerosis complex. Pediatric Radiology, 38(9), 936–952.
Beauchamp, M. H., & Anderson, V. (2010). SOCIAL: An integrative framework for the development of social skills. Psychological Bulletin, 136(1), 39–64.
Bent, C. A., Dissanayake, C., & Barbaro, J. (2015). Mapping the diagnosis of autism spectrum disorders in children aged under 7 years in Australia, 2010-2012. The Medical Journal of Australia, 202(6), 317–320.
Bicudo, N. P., de Menezes Neto, B. F., da Silva de Avo, L. R., Germano, C. M., & Melo, D. G. (2016). Quality of life in adults with Neurofibromatosis 1 in Brazil. Journal of Genetic Counseling, 25(5), 1063–1074.
Bolton, P., Clifford, M., Tye, C., Maclean, C., Humphrey, A., Le Marechal, K., et al. (2015). Intellectual abilities in tuberous sclerosis complex: Risk factors and correlates from the tuberous sclerosis 2000 study. Psychological Medicine, 45(11), 2321–2331.
Borenstein, M., Hedges, L. V., & Higgins, J. P. (2009). Introduction to meta-analysis. Chichester: Wiley..
Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H. (2014). Comprehensive meta-analysis version 3.0 [computer software]. Englewood: Biostat.
Bruni, T. P. (2014). Test review: Social responsiveness scale–second edition (SRS-2). Los Angeles: SAGE Publications Sage CA.
Cantwell, D. P. (1996). Attention deficit disorder: A review of the past 10 years. Journal of the American Academy of Child & Adolescent Psychiatry, 35(8), 978–987.
Charman, T., Pickles, A., Simonoff, E., Chandler, S., Loucas, T., & Baird, G. (2011). IQ in children with autism spectrum disorders: Data from the special needs and autism project (SNAP). Psychological Medicine, 41(3), 619–627.
Cholemkery, H., Kitzerow, J., Rohrmann, S., & Freitag, C. M. (2014). Validity of the social responsiveness scale to differentiate between autism spectrum disorders and disruptive behaviour disorders. European Child & Adolescent Psychiatry, 23(2), 81–93.
Christensen, D. L. (2016). Prevalence and characteristics of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR. Surveillance Summaries, 65(3), 1–23.
Cipolletta, S., Spina, G., & Spoto, A. (2017). Psychosocial functioning, self-image, and quality of life in children and adolescents with neurofibromatosis type 1. Child: Care, Health & Development, 44(2), 260–268. https://doi.org/10.1111/cch.12496.
Clark, T., Feehan, C., Tinline, C., & Vostanis, P. (1999). Autistic symptoms in children with attention deficit-hyperactivity disorder. European Child & Adolescent Psychiatry, 8(1), 50–55.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (p. 2). Hilsdale: Lawrence Earlbaum Associates.
Cohen, J. (1992). Statistical power analysis. Current Directions in Psychological Science, 1(3), 98–101.
Cohen, R., Steinberg, T., Kornreich, L., Aharoni, S., Halevy, A., & Shuper, A. (2015). Brain imaging findings and social/emotional problems in Israeli children with neurofibromatosis type 1. European Journal of Pediatrics, 174(2), 199–203.
Constantino, J. N., & Gruber, C. P. (2012). Social responsiveness scale (Second ed.). Los Angeles: Western Psychological Services.
Constantino, J. N., & Todd, R. D. (2005). Intergenerational transmission of subthreshold autistic traits in the general population. Biological Psychiatry, 57(6), 655–660.
Constantino, J. N., Davis, S. A., Todd, R. D., Schindler, M. K., Gross, M. M., Brophy, S. L., Metzger, L. M., Shoushtari, C. S., Splinter, R., & Reich, W. (2003). Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. Journal of Autism and Developmental Disorders, 33(4), 427–433.
Constantino, J. N., Zhang, Y., Holzhauer, K., Sant, S., Long, K., Vallorani, A., Malik, L., & Gutmann, D. H. (2015). Distribution and within-family specificity of quantitative autistic traits in patients with Neurofibromatosis type I. Journal of Pediatrics, 167(3), 621–626 e621.
Craig, F., Margari, F., Legrottaglie, A. R., Palumbi, R., de Giambattista, C., & Margari, L. (2016). A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment, 12, 1191.
Croen, L. A., Grether, J. K., Hoogstrate, J., & Selvin, S. (2002). The changing prevalence of autism in California. Journal of Autism and Developmental Disorders, 32(3), 207–215.
Dalton, K. M., Nacewicz, B. M., Johnstone, T., Schaefer, H. S., Gernsbacher, M. A., Goldsmith, H. H., Alexander, A. L., & Davidson, R. J. (2005). Gaze fixation and the neural circuitry of face processing in autism. Nature Neuroscience, 8(4), 519–526.
Dilts, C. V., Carey, J. C., Kircher, J. C., Hoffman, R. O., Creel, D., Ward, K., Clark, E., & Leonard, C. O. (1996). Children and adolescents with neurofibromatosis 1: A behavioral phenotype. Journal of Developmental & Behavioral Pediatrics, 17(4), 229–239.
Durkin, M. S., Maenner, M. J., Meaney, F. J., Levy, S. E., DiGuiseppi, C., Nicholas, J. S., Kirby, R. S., Pinto-Martin, J. A., & Schieve, L. A. (2010). Socioeconomic inequality in the prevalence of autism spectrum disorder: Evidence from a US cross-sectional study. PLoS One, 5(7), e11551.
Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455–463.
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315(7109), 629–634.
Evans, D. G., Howard, E., Giblin, C., Clancy, T., Spencer, H., Huson, S. M., & Lalloo, F. (2010). Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service. American Journal of Medical Genetics Part A, 152A(2), 327–332.
Fombonne, E. (2009). Epidemiology of pervasive developmental disorders. Pediatric Research, 65(6), 591–598.
Fung, L. K., & Reiss, A. L. (2015). Moving towards integrative, multi-dimensional research in modern psychiatry: Lessons learned from fragile x syndrome. Biological Psychiatry, 80(2), 100–111.
Garg, S., Green, J., Leadbitter, K., Emsley, R., Lehtonen, A., Evans, D. G., & Huson, S. M. (2013a). Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics, 132(6), e1642–e1648.
Garg, S., Lehtonen, A., Huson, S. M., Emsley, R., Trump, D., Evans, D. G., et al. (2013b). Autism and other psychiatric comorbidity in neurofibromatosis type 1: Evidence from a population-based study. Developmental Medicine & Child Neurology, 55(2), 139–145.
Garg, S., Plasschaert, E., Descheemaeker, M.-J., Huson, S., Borghgraef, M., Vogels, A., Evans, D. G., Legius, E., & Green, J. (2015). Autism spectrum disorder profile in neurofibromatosis type I. Journal of Autism and Developmental Disorders, 45(6), 1649–1657.
Garg, S., Heuvelman, H., Huson, S., Tobin, H., & Green, J. (2016). Sex bias in autism spectrum disorder in neurofibromatosis type 1. Journal of Neurodevelopmental Disorders, 8(1), 1.
Golan, O., Ashwin, E., Granader, Y., McClintock, S., Day, K., Leggett, V., & Baron-Cohen, S. (2010). Enhancing emotion recognition in children with autism spectrum conditions: An intervention using animated vehicles with real emotional faces. Journal of Autism and Developmental Disorders, 40(3), 269–279.
Goodman, R. (1997). The strengths and difficulties questionnaire: A research note. Journal of Child Psychology and Psychiatry, 38(5), 581–586.
Graf, A., Landolt, M. A., Mori, A. C., & Boltshauser, E. (2006). Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1. Journal of Pediatrics, 149(3), 348–353.
Gresham, F., & Elliot, S. (1990). Manual for the social skills rating system. Circle Pines: American Guidance Service.
Group, W. (1998). The WHOQL assessment instrument: Development and general psychometric properties. Social Science and Medicine, 46, 1585–1596.
Hadwin, J., Baron-Cohen, S., Howlin, P., & Hill, K. (1996). Can we teach children with autism to understand emotions, belief, or pretence? Development and Psychopathology, 8(02), 345–365.
Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., Picker, J., Gane, L., & Tranfaglia, M. (2009). Advances in the treatment of fragile X syndrome. Pediatrics, 123(1), 378–390.
Happe, F., Ronald, A., & Plomin, R. (2006). Time to give up on a single explanation for autism. Nature Neuroscience, 9(10), 1218–1220.
Hedges, L. V., & Pigott, T. D. (2004). The power of statistical tests for moderators in meta-analysis. Psychological Methods, 9(4), 426–445.
Hirabaru, K., & Matsuo, M. (2017). Neurological comorbidity in children with neurofibromatosis type 1. Pediatrics International, 60(1), 70–75. https://doi.org/10.1111/ped.13388.
Hofman, K. J., Harris, E. L., Bryan, R. N., & Denckla, M. B. (1994). Neurofibromatosis type 1: The cognitive phenotype. Journal of Pediatrics, 124(4), S1–S8.
Huedo-Medina, T. B., Sánchez-Meca, J., Marín-Martínez, F., & Botella, J. (2006). Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychological Methods, 11(2), 193–206.
Huijbregts, S. C., & de Sonneville, L. M. (2011). Does cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1? Behavior Genetics, 41(3), 430–436.
Huijbregts, S., Jahja, R., De Sonneville, L., De Breij, S., & Swaab-Barneveld, H. (2010). Social information processing in children and adolescents with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 52(7), 620–625.
Huijbregts, S. C., Loitfelder, M., Rombouts, S. A., Swaab, H., Verbist, B. M., Arkink, E. B., van Buchem, M. A., & Veer, I. M. (2015). Cerebral volumetric abnormalities in Neurofibromatosis type 1: Associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms. Journal of Neurodevelopmental Disorders, 7(1), 32.
Hus, V., Bishop, S., Gotham, K., Huerta, M., & Lord, C. (2013). Factors influencing scores on the social responsiveness scale. Journal of Child Psychology and Psychiatry, 54(2), 216–224.
Hyman, S. L., Shores, A., & North, K. N. (2005). The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology, 65(7), 1037–1044.
Hyman, S. L., Shores, A. E., & North, K. N. (2006). Learning disabilities in children with neurofibromatosis type 1: Subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Developmental Medicine & Child Neurology, 48(12), 973–977.
Jeste, S. S., & Geschwind, D. H. (2014). Disentangling the heterogeneity of autism spectrum disorder through genetic findings. Nature Reviews Neurology, 10(2), 74–81.
Johnson, N. S., Saal, H. M., Lovell, A. M., & Schorry, E. K. (1999). Social and emotional problems in children with neurofibromatosis type 1: Evidence and proposed interventions. Journal of Pediatrics, 134(6), 767–772.
Johnson, W., Bouchard, T. J., Krueger, R. F., McGue, M., & Gottesman, I. I. (2004). Just one g: Consistent results from three test batteries. Intelligence, 32(1), 95–107.
Johnson, H., Wiggs, L., Stores, G., & Huson, S. M. (2005). Psychological disturbance and sleep disorders in children with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 47(4), 237–242.
Kenworthy, L., Case, L., Harms, M. B., Martin, A., & Wallace, G. L. (2010). Adaptive behavior ratings correlate with symptomatology and IQ among individuals with high-functioning autism spectrum disorders. Journal of Autism and Developmental Disorders, 40(4), 416–423.
Klein-Tasman, B. P., Janke, K. M., Luo, W., Casnar, C. L., Hunter, S. J., Tonsgard, J., Trapane, P., van der Fluit, F., & Kais, L. A. (2014). Cognitive and psychosocial phenotype of young children with neurofibromatosis-1. Journal of the International Neuropsychological Society, 20(1), 88–98.
Korf, B. R. (2002). Clinical features and pathobiology of neurofibromatosis 1. Journal of Child Neurology, 17(8), 573–577.
Krab, L. C., de Goede-Bolder, A., Aarsen, F. K., Pluijm, S. M., Bouman, M. J., van der Geest, J. N., et al. (2008). Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: A randomized controlled trial. Journal of the American Medical Association, 300(3), 287–294.
Lai, M. C., Lombardo, M. V., & Baron-Cohen, S. (2014). Autism. Lancet, 383(9920), 896–910.
Lainhart, J. E., Bigler, E. D., Bocian, M., Coon, H., Dinh, E., Dawson, G., Deutsch, C. K., Dunn, M., Estes, A., Tager-Flusberg, H., Folstein, S., Hepburn, S., Hyman, S., McMahon, W., Minshew, N., Munson, J., Osann, K., Ozonoff, S., Rodier, P., Rogers, S., Sigman, M., Spence, M. A., Stodgell, C. J., & Volkmar, F. (2006). Head circumference and height in autism: A study by the collaborative program of excellence in autism. American Journal of Medical Genetics Part A, 140(21), 2257–2274.
Le Couteur, A., Lord, C., & Rutter, M. (2003). The autism diagnostic interview-revised (ADI-R). Los Angeles: Western Psychological Services.
Lehtonen, A., Howie, E., Trump, D., & Huson, S. M. (2013). Behaviour in children with neurofibromatosis type 1: Cognition, executive function, attention, emotion, and social competence. Developmental Medicine & Child Neurology, 55(2), 111–125.
Lewis, A. K., Porter, M. A., Williams, T. A., North, K. N., & Payne, J. M. (2016). Social competence in children with neurofibromatosis type 1: Relationships with psychopathology and cognitive ability. Journal of Childhood & Developmental Disorders, 2(2), 1–12.
Lewis, A. K., Porter, M. A., Williams, T. A., Bzishvili, S., North, K. N., & Payne, J. M. (2017). Facial emotion recognition, face scan paths, and face perception in children with neurofibromatosis type 1. Neuropsychology, 31(4), 361–370.
Li, W., Cui, Y., Kushner, S. A., Brown, R. A., Jentsch, J. D., Frankland, P. W., et al. (2005). The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Current Biology, 15(21), 1961–1967.
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P., et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. British Medical Journal, 339(jul21 1), b2700.
Loitfelder, M., Huijbregts, S. C., Veer, I. M., Swaab, H. S., Van Buchem, M. A., Schmidt, R., et al. (2015). Functional connectivity changes and executive and social problems in Neurofibromatosis type I. Brain Connectivity, 5(5), 312–320.
Loomes, R., Hull, L., & Mandy, W. P. L. (2017). What is the male-to-female ratio in autism Spectrum disorder? A systematic review and meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 56(6), 466–474.
Lord, C., Risi, S., Lambrecht, L., Cook Jr., E. H., Leventhal, B. L., DiLavore, P. C., et al. (2000). The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30(3), 205–223.
Love, E. B., Nowicki Jr., S., & Duke, M. P. (1994). The Emory Dyssemia index: A brief screening instrument for the identification of nonverbal language deficits in elementary school children. The Journal of Psychology, 128(6), 703–705.
Lowe, M. R., & Cautela, J. R. (1978). A self-report measure of social skill. Behavior Therapy, 9(4), 535–544.
Luteijn, E., Minderaa, R., & Jackson, A. (2002). Vragenlijst voor Inventarisatie van Sociaal gedrag bij Kinderen, Handleiding [Children’s Social Behaviour Questionnaire, Manual]. Lisse: Swets & Zeitlinger.
Maenner, M. J., Schieve, L. A., Rice, C. E., Cunniff, C., Giarelli, E., Kirby, R. S., Lee, L. C., Nicholas, J. S., Wingate, M. S., & Durkin, M. S. (2013). Frequency and pattern of documented diagnostic features and the age of autism identification. Journal of the American Academy of Child & Adolescent Psychiatry, 52(4), 401–413 e408.
Mansbach-Kleinfeld, I., Apter, A., Farbstein, I., Levine, S. Z., & Ponizovsky, A. M. (2010). A population-based psychometric validation study of the strengths and difficulties questionnaire - hebrew version. Frontiers in Psychiatry, 1, 151.
Martin, S., Wolters, P., Baldwin, A., Gillespie, A., Dombi, E., Walker, K., et al. (2012). Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: Relationships with cognitive, disease, and environmental variables. Journal of Pediatric Psychology, 37(7), 713–724.
Masi, A., DeMayo, M. M., Glozier, N., & Guastella, A. J. (2017). An overview of autism spectrum disorder, heterogeneity and treatment options. Neuroscience Bulletin, 1–11.
Masten, A. S., Morison, P., & Pellegrini, D. S. (1985). A revised class play method of peer assessment. Developmental Psychology, 21(3), 523–533.
Mautner, V. F., Kluwe, L., Thakker, S. D., & Leark, R. A. (2002). Treatment of ADHD in neurofibromatosis type 1. Developmental Medicine & Child Neurology, 44(3), 164–170.
Mayes, S. D., Calhoun, S. L., Mayes, R. D., & Molitoris, S. (2012). Autism and ADHD: Overlapping and discriminating symptoms. Research in Autism Spectrum Disorders, 6(1), 277–285.
McLoyd, V. C. (1998). Socioeconomic disadvantage and child development. American Psychologist, 53(2), 185–204.
Molosh, A. I., Johnson, P. L., Spence, J. P., Arendt, D., Federici, L. M., Bernabe, C., et al. (2014). Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase. Nature Neuroscience, 17(11), 1583–1590.
Moos, R. H., & Moos, B. S. (1994). Family environment scale manual. Consulting Psychologists Press.
Morris, S. M., Acosta, M. T., Garg, S., Green, J., Huson, S., Legius, E., et al. (2016). Disease burden and symptom structure of autism in Neurofibromatosis type 1: A study of the international NF1-ASD consortium team (INFACT). JAMA Psychiatry, 73(12), 1276–1284.
Neurofibromatosis. (1988). Neurofibromatosis. Conference statement. National Institutes of Health consensus development conference. Archives of Neurology, 45(5), 575–578.
Nisbett, R. E., Aronson, J., Blair, C., Dickens, W., Flynn, J., Halpern, D. F., et al. (2012). Intelligence: New findings and theoretical developments. American Psychologist, 67(2), 130–159.
Noll, R. B., Reiter-Purtill, J., Moore, B. D., Schorry, E. K., Lovell, A. M., Vannatta, K., et al. (2007). Social, emotional, and behavioral functioning of children with NF1. American Journal of Medical Genetics Part A, 143A(19), 2261–2273.
Packer, A. (2012). RAS pathway, a potentially unifying theory of autism. Simons Foundation Autism Research Initiative, 13.
Payne, J. M. (2013). Autism spectrum disorder symptomatology in children with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 55(2), 100–101.
Payne, J. M., Moharir, M. D., Webster, R., & North, K. N. (2010). Brain structure and function in neurofibromatosis type 1: Current concepts and future directions. Journal of Neurology, Neurosurgery and Psychiatry, 81(3), 304–309.
Payne, J. M., Barton, B., Ullrich, N. J., Cantor, A., Hearps, S. J., Cutter, G., et al. (2016a). Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1. Neurology, 87(24), 2575–2584.
Payne, J. M., Porter, M., Pride, N. A., & North, K. N. (2016b). Theory of mind in children with Neurofibromatosis type 1. Neuropsychology, 30(4), 439–448.
Plasschaert, E., Descheemaeker, M.-J., Van Eylen, L., Noens, I., Steyaert, J., & Legius, E. (2015). Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 168(1), 72–80.
Plasschaert, E., Van Eylen, L., Descheemaeker, M. J., Noens, I., Legius, E., & Steyaert, J. (2016). Executive functioning deficits in children with neurofibromatosis type 1: The influence of intellectual and social functioning. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 171(3), 348–362.
Pride, N. A., Crawford, H., Payne, J. M., & North, K. N. (2013). Social functioning in adults with neurofibromatosis type 1. Research in Developmental Disabilities, 34(10), 3393–3399.
Pride, N. A., Korgaonkar, M. S., Barton, B., Payne, J. M., Vucic, S., & North, K. N. (2014). The genetic and neuroanatomical basis of social dysfunction: Lessons from neurofibromatosis type 1. Human Brain Mapping, 35(5), 2372–2382.
Pride, N. A., Korgaonkar, M. S., North, K. N., Barton, B., & Payne, J. M. (2017a). The neural basis of deficient response inhibition in children with neurofibromatosis type 1: Evidence from a functional MRI study. Cortex, 93, 1–11.
Pride, N. A., Korgaonkar, M. S., North, K. N., & Payne, J. M. (2017b). Impaired engagement of the ventral attention system in neurofibromatosis type 1. Brain Imaging and Behavior, 1–10.
Pua, E. P. K., Bowden, S. C., & Seal, M. L. (2017). Autism spectrum disorders: Neuroimaging findings from systematic reviews. Research in Autism Spectrum Disorders, 34, 28–33.
Renk, K., & Phares, V. (2004). Cross-informant ratings of social competence in children and adolescents. Clinical Psychology Review, 24(2), 239–254.
Reynolds, C. R., & Kamphaus, R. W. (1998). BASC: Behavior assessment system for children: Manual: American Guidance Service.
Robins, D. L., & Dumont-Mathieu, T. M. (2006). Early screening for autism spectrum disorders: Update on the modified checklist for autism in toddlers and other measures. Journal of Developmental & Behavioral Pediatrics, 27(2 Suppl), S111–S119.
Rutter, M., Bailey, A., & Lord, C. (2003). The Social Communication Questionnaire: Manual: Western psychological services.
Schatz, J., & Hamdan-Allen, G. (1995). Effects of age and IQ on adaptive behavior domains for children with autism. Journal of Autism and Developmental Disorders, 25(1), 51–60.
Schwetye, K. E., & Gutmann, D. H. (2014). Cognitive and behavioral problems in children with neurofibromatosis type 1: Challenges and future directions. Expert Review of Neurotherapeutics, 14(10), 1139–1152.
Speer, L. L., Cook, A. E., McMahon, W. M., & Clark, E. (2007). Face processing in children with autism: Effects of stimulus contents and type. Autism, 11(3), 265–277.
Spence, S. H. (1995). Social skills training: Enhancing social competence with children and adolescents: Nfer-Nelson.
Thomas, P., Zahorodny, W., Peng, B., Kim, S., Jani, N., Halperin, W., et al. (2012). The association of autism diagnosis with socioeconomic status. Autism, 16(2), 201–213.
Tidyman, W. E., & Rauen, K. A. (2009). The RASopathies: Developmental syndromes of Ras/MAPK pathway dysregulation. Current Opinion in Genetics & Development, 19(3), 230–236.
Tinker, J., Carbone, P. S., Viskochil, D., Mathiesen, A., Ma, K. N., & Stevenson, D. A. (2014). Screening children with neurofibromatosis type 1 for autism spectrum disorder. American Journal of Medical Genetics Part A, 164A(7), 1706–1712.
van der Vaart, T., Plasschaert, E., Rietman, A. B., Renard, M., Oostenbrink, R., Vogels, A., et al. (2013). Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): A randomised, placebo-controlled trial. The Lancet Neurology, 12(11), 1076–1083.
van der Vaart, T., Rietman, A. B., Plasschaert, E., Legius, E., Elgersma, Y., Moll, H. A., et al. (2016). Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1. Neurology, 86(2), 154–160.
Van Eeghen, A. M., Pulsifer, M. B., Merker, V. L., Neumeyer, A. M., Van Eeghen, E. E., Thibert, R. L., et al. (2013). Understanding relationships between autism, intelligence, and epilepsy: A cross-disorder approach. Developmental Medicine & Child Neurology, 55(2), 146–153.
Varni, J. W., Seid, M., & Rode, C. A. (1999). The PedsQL™: Measurement model for the pediatric quality of life inventory. Medical Care, 37(2), 126–139.
Vogels, T., Verrips, G., Koopman, H., Theunissen, N., Fekkes, M., & Kamphuis, R. (2000). TACQOL manual: Parent form and child form. Leiden: Leiden Center for Child Health and Pediatrics LUMC-TNO.
Von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2008). The strengthening the reporting of observational studies in epidemiology [STROBE] statement: Guidelines for reporting observational studies. Gaceta Sanitaria, 22(2), 144–150.
Walsh, K. S., Velez, J. I., Kardel, P. G., Imas, D. M., Muenke, M., Packer, R. J., et al. (2013). Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Developmental Medicine & Child Neurology, 55(2), 131–138.
Wang, D. L., Smith, K. B., Esparza, S., Leigh, F. A., Muzikansky, A., Park, E. R., et al. (2012a). Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome. Genetics in Medicine, 14(12), 977–982.
Wang, Y., Kim, E., Wang, X., Novitch, B. G., Yoshikawa, K., Chang, L.-S., et al. (2012b). ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities. Cell, 150(4), 816–830.
Werling, D. M., & Geschwind, D. H. (2013). Sex differences in autism spectrum disorders. Current Opinion in Neurology, 26(2), 146–153.
Williams, J., Scott, F., Stott, C., Allison, C., Bolton, P., Baron-Cohen, S., et al. (2005). The CAST (childhood Asperger syndrome test): Test accuracy. Autism, 9(1), 45–68.
Williams, V. C., Lucas, J., Babcock, M. A., Gutmann, D. H., Korf, B., & Maria, B. L. (2009). Neurofibromatosis type 1 revisited. Pediatrics, 123(1), 124–133.
Yeates, K. O., Swift, E., Taylor, H. G., Wade, S. L., Drotar, D., Stancin, T., et al. (2004). Short- and long-term social outcomes following pediatric traumatic brain injury. Journal of International Neuropsychological Society, 10(3), 412–426.
Yeates, K. O., Bigler, E. D., Dennis, M., Gerhardt, C. A., Rubin, K. H., Stancin, T., et al. (2007). Social outcomes in childhood brain disorder: A heuristic integration of social neuroscience and developmental psychology. Psychological Bulletin, 133(3), 535–556.
Acknowledgments
The authors acknowledge the assistance of Poh Chua (RCH) for guidance on conducting systematic database searches.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
ESM 1
(DOCX 53.9 kb)
Rights and permissions
About this article
Cite this article
Chisholm, A.K., Anderson, V.A., Pride, N.A. et al. Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis. Neuropsychol Rev 28, 317–340 (2018). https://doi.org/10.1007/s11065-018-9380-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11065-018-9380-x